Aspirin in Primary Prevention of Stroke-Review of Evidence Through the Needs of Indian Clinical Settings Dr. Rahul R. Patil7 July 2025 11:42 AM ISTIntroduction: Stroke Burden and Aspirin's RoleThe stroke burden in India is substantial and growing, with an incidence of 119-145 per 100,000 annually...
Identifying Candidates for Aspirin in Primary Prevention: Men Aged 40-50 with Hypertension, Dyslipidemia, and Familial ASCVD Risk Dr. Pradeep Haranahalli1 July 2025 11:03 AM ISTPremature ASCVD: Why Age 40-50 Males Need Closer Attention? Premature ASCVD is rising sharply in Indian men aged 40-50, demanding earlier...
Beyond BMI: Why Pioglitazone Deserves a Place in Managing 'Thin-Fat' Type 2 Diabetes in India Dr. Kaushik Pandit26 Jun 2025 11:03 AM ISTThin-Fat Paradox in Indian T2DM - A Distinct Metabolic Challenge: In the Indian population, the 'thin-fat' phenotype-normal BMI with excess visceral...
How to Improve Adherence in Hypertensive Patients? Bridging the Gap with CONNECT Tool Dr. K.R.K.S Raju25 Jun 2025 11:30 AM ISTThe Hidden Crisis: Uncontrolled Hypertension in IndiaHypertension significantly contributes to a wide spectrum of cardiovascular and metabolic...
Aspirin in Primary Prevention: Prudent Guideline-Based Approach Prof. (Dr.) J.P.S. Sawhney13 Jun 2025 11:44 AM ISTAspirin in Primary Prevention: Need for Delineating High CV-Risk, Low-Bleeding-Risk Profiles: Aspirin in primary prevention requires a nuanced,...
Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates Dr. Milind Desai31 May 2025 10:53 AM ISTPremature ASCVD in IndiaIn India, over 50% of cardiovascular disease (CVD) deaths occur before 50 years, and 25% of myocardial infarction (MI) events...
Relevance of Pioglitazone in Indian T2DM Care Continuum Dr. Vijay Panikar27 May 2025 11:30 AM ISTIndia is experiencing a rising burden of type 2 diabetes (T2D), affecting 11.4% of adults. Hypertension (35.5%), generalized obesity (28.6%),...
Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study Dr. Garima Soni22 May 2025 11:30 AM ISTAhmedabad: Azmarda, an innovator brand of Sacubitril/Valsartan, demonstrated superior efficacy compared to generic Sacubitril/Valsartan in patients...
Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases Dr. Sanjay Mittal14 May 2025 11:37 AM ISTCardiovascular diseases (CVD) account for 24.8% of all deaths in India, with an age-standardized death rate of 272 per 100,000-higher than the global...
Aspirin in Primary Prevention- When to Consider? Dr A B Chandorkar9 May 2025 11:16 AM ISTReframing Aspirin's Role in Primary Prevention: Evolving evidence has refined our understanding of aspirin's role in primary prevention. While earlier...
Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates Dr. Salil Vaidya28 April 2025 10:25 AM ISTCVD Risk in Women After 40: Cardiovascular disease (CVD) is the leading cause of death in individuals with type 2 diabetes (T2D) and hypertension. (1)...
Indian CV Risk Factors and Emerging Evidence for Aspirin in Primary Prevention- What's New? Dr. Jay Shah5 April 2025 11:32 AM ISTCardiovascular diseases (CVDs) remain the leading cause of mortality and disability in India, contributing to 31.8% of deaths. Noncommunicable...
